BFH772
BFH772 is a potent oral VEGFR2 inhibitor, which is highly effective at targeting VEGFR2 kinase with an IC50 value of 3 nM[1].
Product Specifications
CAS Number
[890128-81-1]
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
VEGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/BFH772.html
Concentration
10mM
Purity
96.67
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(NC1=CC(C(F)(F)F)=CC=C1)C2=CC=CC3=CC(OC4=NC=NC(CO)=C4)=CC=C32
Molecular Formula
C23H16F3N3O3
Molecular Weight
439.39
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Bold G, et al. A Novel Potent Oral Series of VEGFR2 Inhibitors Abrogate Tumor Growth by Inhibiting Angiogenesis. J Med Chem. 2016 Jan 14;59 (1) :132-46.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
VEGFR2/KDR/Flk-1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6199847-01 0.1 mL
CAB39L (Calcium-binding Protein 39-like, Antigen MLAA-34, MO25beta, Mo25-like Protein, FLJ12577) (MaxLight 490)
Ask
View Details 
MBS6199847-02 5x 0.1 mL
CAB39L (Calcium-binding Protein 39-like, Antigen MLAA-34, MO25beta, Mo25-like Protein, FLJ12577) (MaxLight 490)
Ask
View Details 